Puriblood Medical Co., Ltd. (TPEX:6847)
Taiwan · Delayed Price · Currency is TWD 74.10
+0.60 (0.82%)
Feb 11, 2026, 2:56 PM CST
Puriblood Medical Cash Flow Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
Period Ending | Jun '25 Jun 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
Net Income | -7.47 | -5.37 | -51.6 | 16.53 | -38.02 | -2.78 |
Depreciation & Amortization | 7.94 | 8.17 | 7.99 | 7.68 | 6.27 | 4.82 |
Other Amortization | 0.09 | 0.12 | 0.11 | 0.09 | 0.16 | 0.34 |
Loss (Gain) From Sale of Assets | - | 0.02 | - | 0.15 | - | 0.59 |
Loss (Gain) From Sale of Investments | 8.62 | 7.03 | 3.75 | -10.05 | 1.9 | -1.13 |
Loss (Gain) on Equity Investments | 4.7 | 1.06 | 0.96 | 0.13 | 0.07 | 1.53 |
Stock-Based Compensation | 0.1 | - | - | - | 0.09 | 0.23 |
Other Operating Activities | -33.94 | -23.23 | -2.96 | 0.4 | 2.03 | 0.05 |
Change in Accounts Receivable | -0.02 | -6.32 | 10.07 | -10.33 | 7.13 | -13.42 |
Change in Inventory | -2.62 | -5.72 | 6.62 | -13.51 | -11.96 | -2.04 |
Change in Accounts Payable | 0.98 | -7.12 | 11.27 | 2.06 | 1.17 | 0.23 |
Change in Unearned Revenue | 8.75 | 0.26 | -7.88 | 7.41 | -0.02 | -0.14 |
Change in Other Net Operating Assets | -10.85 | 1.42 | 48.33 | -31.4 | -12.5 | 2.1 |
Operating Cash Flow | -23.73 | -29.68 | 26.65 | -30.83 | -43.68 | -9.62 |
Capital Expenditures | -1.09 | -2.06 | -6.25 | -2.21 | -3.15 | -9.85 |
Sale of Property, Plant & Equipment | 0.67 | 0.67 | - | 0.12 | - | 0.11 |
Sale (Purchase) of Intangibles | - | - | -0.1 | -9.25 | -1.95 | -0.24 |
Investment in Securities | 2.5 | - | 3 | -13.5 | -20 | -5.75 |
Other Investing Activities | -0.02 | -0.01 | 0.1 | -0.8 | 0.74 | -0.09 |
Investing Cash Flow | 2.06 | -1.4 | -3.25 | -25.64 | -24.35 | -15.82 |
Long-Term Debt Issued | - | 20 | 28.21 | 30 | - | 4.03 |
Total Debt Issued | 25 | 20 | 28.21 | 30 | - | 4.03 |
Short-Term Debt Repaid | - | - | - | - | - | -11 |
Long-Term Debt Repaid | - | -19.8 | -33.18 | -3.66 | -3.59 | -1.15 |
Total Debt Repaid | -17.9 | -19.8 | -33.18 | -3.66 | -3.59 | -12.15 |
Net Debt Issued (Repaid) | 7.1 | 0.2 | -4.97 | 26.34 | -3.59 | -8.12 |
Issuance of Common Stock | - | - | - | - | 108.3 | 120 |
Other Financing Activities | - | - | -0.44 | -2.24 | -4.65 | 0.17 |
Financing Cash Flow | 7.1 | 0.2 | -5.42 | 24.1 | 100.06 | 112.05 |
Net Cash Flow | -14.56 | -30.87 | 17.98 | -32.37 | 32.03 | 86.61 |
Free Cash Flow | -24.82 | -31.74 | 20.4 | -33.04 | -46.83 | -19.47 |
Free Cash Flow Margin | -21.15% | -28.68% | 16.28% | -24.04% | -85.78% | -50.38% |
Free Cash Flow Per Share | -1.74 | -2.23 | 1.43 | -2.32 | -4.02 | -2.26 |
Cash Interest Paid | 0.9 | 0.81 | 1.35 | 1.32 | 0.87 | 1 |
Cash Income Tax Paid | 0.02 | 0.08 | 0.09 | 0.01 | - | - |
Levered Free Cash Flow | 5.25 | -11.75 | 37.16 | -48.33 | -36.87 | -15.85 |
Unlevered Free Cash Flow | 5.81 | -11.25 | 37.97 | -47.66 | -36.44 | -15.2 |
Change in Working Capital | -3.76 | -17.49 | 68.4 | -45.76 | -16.17 | -13.27 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.